Parathyroidectomy: Whom and when?
- 1 June 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (85) , S97-S100
- https://doi.org/10.1046/j.1523-1755.63.s85.23.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directionsNephrology Dialysis Transplantation, 2002
- Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.Nephrology Dialysis Transplantation, 2002
- Vitamin D analogues: how do they differ and what is their clinical role?Nephrology Dialysis Transplantation, 2001
- Recent developments in the management of secondary hyperparathyroidismKidney International, 2001
- Arterial stiffening and vascular calcifications in end‐stage renal diseaseNephrology Dialysis Transplantation, 2000
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisNew England Journal of Medicine, 2000
- Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*Nephrology Dialysis Transplantation, 1999
- Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients—the Japanese strategyNephrology Dialysis Transplantation, 1999
- Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failureKidney International, 1999
- Factors associated with calcification of the abdominal aorta in hemodialysis patientsKidney International, 1999